Research Alliance with Bayer
Bayer AG is a multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world. It has core competencies in the life science fields of health care and nutrition and one of the Top 20 pharmaceutical companies world-wide. Bayer specialises in prescription products for oncology, cardiology, eye diseases and women’s healthcare.
About the Oxford-Bayer Alliance
The University of Oxford collaborates with Bayer on a number of projects focused around Women’s Health. The alliance has the specific aim of identifying and characterising novel drug targets for women’s unmet health needs in endometriosis, uterine fibroids and polycystic ovarian syndrome (PCOS). The pathways and mechanisms underlying these conditions remain poorly understood. A comprehensive programme to dissect the disease-causing processes is being undertaken. An immense benefit to the alliance is the availability of scarce samples through the Oxford University Hospital Trust.
Therapeutic areas of interest
- Women's health
- Uterine fibroids
- Polycystic Ovarian Syndrome (PCOS)
- Co-applicants on a grant
- Sponsored research collaborations